Danish medical journalHumansInfliximabRetrospective StudiesFemaleMale
No post-infusion reactions after infliximab or vedolizumab.
Lars Koch Hansen, Karina Winther Andersen, Sara Emmerich Jensen, Michael Dam Jensen
Published: 202510.61409/A03250206
Abstract
INTRODUCTION: Biologic therapies like infliximab and vedolizumab effectively treat inflammatory bowel disease (IBD), but post-infusion observation consumes considerable clinical resources. This study evaluated whether post-infusion observation period…
Preview only. Read the full abstract at the source